Clinical Trial

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is to evaluate the efficacy and safety of chemotherapy combined with or without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer
Trial Details
NCT Number NCT07132528
Lead Sponsor Liaoning Cancer Hospital & Institute
Conditions Gastric / Gastroesophageal Junction Adenocarcinoma
Enrollment 1,000 participants
Start Date 2025-08-31
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-20